Insight on Pharmaceuticals and Healthcare in United Kingdom

Published within

« | ... | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ... | » »|

Type Product title / description Pub Price
Report
Report

Epidemiology: Hepatitis C - Hepatitis C virus will remain a prevalent bloodborne disease in the seven major markets, primarily transmitted through injection drug use

Overview of hepatitis C and a review of epidemiology literature. This report provides in-depth analysis of patient populations, 10 year prevalent forecast, and key patient segments, including age, gender and genotype, across the seven major markets.

Published By Datamonitor
07 Feb 2011 $2800
Buy
Report
Report

Forecast Insight: Antibacterials – Generic erosion of the market leaders will eclipse growth from new product launches

This report explores key issues in the antibacterials market across the seven major markets. It contains an in-depth assessment of key marketed antibacterial brands, an analysis of market dynamics over the last 4 years, and a 10-year sales forecast.

Published By Datamonitor
09 Feb 2011 $6400
Buy
Report
Report

Epidemiology: Cervical Cancer - The small decrease in cervical cancer cases over the next decade in the seven major markets is driven by decreasing incidence rates

Overview of cervical cancer definition and a review of epidemiology literature. This report provides in-depth analysis of patient populations, a 10 year incident case forecast, and key patient segments across the seven major markets.

Published By Datamonitor
15 Feb 2011 $2800
Buy
Report
Report

Pipeline Insight: Antibacterials

This report provides an in-depth discussion of the antibacterial drugs pipeline. It contains profiles of key late-stage candidates as well as an overview of earlier stage pipeline dynamics, unmet needs and R&D trends.

Published By Datamonitor
17 Feb 2011 $3600
Buy
Report
Report

Pharmaceutical Key Trends 2011: Biosimilar Market Overview

Comparative analysis of biosimilar drivers and resistors, key players, market access, pricing, and future launches across multiple markets including: the US, Japan, France, Germany, Italy, Spain, the UK, Australia, Brazil, Russia, India and China.

Published By Datamonitor
23 Feb 2011 $2800
Buy
Report
Report

Pharmaceutical Key Trends 2011: Prescription Pharmaceutical Sales Overview

An analysis of global sales forecasts for the top 50 companies during 2010–15.

Published By Datamonitor
28 Feb 2011 $1520
Buy
Report
Report

Epidemiology: Autism Spectrum Disorders - Increasing recognition drives growth of treatable population

Overview of autism spectrum disorder definition and a review of epidemiology literature. This report provides in-depth analysis of patient populations, a 10 year prevalent case forecast, and key patient segments across the seven major markets.

Published By Datamonitor
28 Feb 2011 $2800
Buy
Report
Report

Epidemiology: Endometrial Cancer - Postmenopausal women are at the most risk for developing endometrial cancer; aging populations will drive an increase in cases

Overview of endometrial cancer defintion and a review of the epidemiology literature. This report provides in-depth analysis of patient populations, a 10 year incident case forecast, and key patient segments across the seven major markets.

Published By Datamonitor
11 Mar 2011 $2800
Buy
Report
Report

R&D Trends: Hepatitis C

As new hepatitis C products advance into clinical development, the design of clinical studies and treatment regimens is becoming increasingly complex. This module reviews pipeline trends, clinical trial design and future treatment paradigms.

Published By Datamonitor
14 Mar 2011 $2800
Buy

Order this report by 20th May 2011 and receive a 15% discount

To take advantage of this offer enter Promo Code CMDN17 when prompted in the checkout

More information

Report
Report

R&D Trends: Psoriasis - Pipeline outlook following withdrawal of key regulatory filing

Review of candidates in development for psoriasis across the seven major markets, highlighting key trends, as well as detailed analyses of clinical trial design, innovative early-stage projects and hypothesizing on how future treatment may evolve

Published By Datamonitor
16 Mar 2011 $2800
Buy

« | ... | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ... | » »|

No help is available.